IPO vs CURE
Comparison between RENAISSANCE IPO ETF (IPO, ETF) and DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF).
5-Year PerformanceCURE has outperformed IPO, delivering a return of +2.3% compared to -2.5%
IPO vs CURE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
IPO
$138M
CURE
$138M
Expense Ratio
IPO
0.60%
CURE
N/A
Max Drawdown
Winner
IPO
68.76%
CURE
69.19%
Sharpe Ratio
IPO
0.74
Winner
CURE
0.80
5Y Beta
IPO
1.49
Winner
CURE
1.38
P/E Ratio
IPO
184.80
Winner
CURE
28.04
Forward P/E
IPO
39.85
Winner
CURE
17.34
PEG Ratio
IPO
0.49
CURE
N/A
5Y Dividends CAGR
IPO
38.29%
Winner
CURE
63.21%
5Y EPS CAGR
IPO
N/A
CURE
12.58%
Debt to Equity
IPO
N/A
CURE
53.58%
P/S Ratio
IPO
4.86
Winner
CURE
1.48
P/B Ratio
IPO
6.71
Winner
CURE
4.58
IPO vs CURE - Holdings Comparison
IPO and CURE have 1 common holdings. Overlap is -3.15%
IPO's top 25 holdings weight is 91.37%. CURE's top 25 holdings weight is 91.92%.
| Rank | IPO | CURE |
|---|---|---|
| #1 | ASTERA LABS INC (ALAB) - 12.57% | GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35% |
| #2 | ARM HOLDINGS PLC ADR (ARM) - 12.40% | ELI LILLY AND CO (LLY) - 11.75% |
| #3 | COREWEAVE INC ORDINARY SHARES CLASS A (CRWV) - 9.81% | DREYFUS GOVT CASH MAN INS (n/a) - 10.69% |
| #4 | KENVUE INC (KVUE) - 7.90% | JOHNSON & JOHNSON (JNJ) - 7.72% |
| #5 | REDDIT INC CLASS A SHARES (RDDT) - 5.76% | GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02% |
| #6 | VIKING HOLDINGS LTD (VIK) - 4.56% | ABBVIE INC (ABBV) - 5.24% |
| #7 | CIRCLE INTERNET GROUP INC ORDINARY SHARES CLASS A (CRCL) - 3.57% | UNITEDHEALTH GROUP INC (UNH) - 4.75% |
| #8 | MEDLINE INC ORDINARY SHARES CLASS A (MDLN) - 3.55% | MERCK & CO INC (MRK) - 4.14% |
| #9 | RUBRIK INC CLASS A SHARES (RBRK) - 3.04% | AMGEN INC (AMGN) - 2.52% |
| #10 | AMERICAN HEALTHCARE REIT INC ORDINARY SHARES (AHR) - 2.78% | THERMO FISHER SCIENTIFIC INC (TMO) - 2.34% |
| #11 | KASPI.KZ JSC ADS (KSPI) - 2.58% | GILEAD SCIENCES INC (GILD) - 2.31% |
| #12 | CAVA GROUP INC (CAVA) - 2.50% | INTUITIVE SURGICAL INC (ISRG) - 2.16% |
| #13 | UL SOLUTIONS INC CLASS A COMMON STOCK (ULS) - 2.41% | ABBOTT LABORATORIES (ABT) - 2.10% |
| #14 | BRIGHTSPRING HEALTH SERVICES INC (BTSG) - 2.40% | PFIZER INC (PFE) - 2.05% |
| #15 | MAPLEBEAR INC (CART) - 2.17% | BRISTOL-MYERS SQUIBB CO (BMY) - 1.65% |
| #16 | STANDARDAERO INC (SARO) - 1.93% | CVS HEALTH CORP (CVS) - 1.61% |
| #17 | AMER SPORTS INC (AS) - 1.71% | VERTEX PHARMACEUTICALS INC (VRTX) - 1.54% |
| #18 | TEMPUS AI INC CLASS A COMMON STOCK (TEM) - 1.44% | DANAHER CORP (DHR) - 1.51% |
| #19 | LEGENCE CORP ORDINARY SHARES CLASS A (LGN) - 1.37% | STRYKER CORP (SYK) - 1.50% |
| #20 | SERVICETITAN INC CLASS A ORDINARY SHARES (TTAN) - 1.29% | MEDTRONIC PLC (MDT) - 1.38% |
| #21 | ATMUS FILTRATION TECHNOLOGIES INC (ATMU) - 1.27% | MCKESSON CORP (MCK) - 1.29% |
| #22 | FORGENT POWER SOLUTIONS INC ORDINARY SHARES CLASS A (FPS) - 1.25% | BOSTON SCIENTIFIC CORP (BSX) - 1.19% |
| #23 | FIGMA INC CLASS A (FIG) - 1.23% | ELEVANCE HEALTH INC (ELV) - 1.19% |
| #24 | KARMAN HOLDINGS INC (KRMN) - 0.96% | THE CIGNA GROUP (CI) - 1.03% |
| #25 | LINEAGE INC REIT (LINE) - 0.92% | REGENERON PHARMACEUTICALS INC (REGN) - 0.89% |
| Total Holdings | 49 | 65 |
IPO vs CURE - Historical Returns
Returns include dividend reinvestment.
1M
IPO
+4.53%
Winner
CURE
+14.77%
3M
Winner
IPO
+24.03%
CURE
-5.02%
6M
Winner
IPO
+12.56%
CURE
-6.22%
1Y
IPO
+24.72%
Winner
CURE
+34.45%
5Y(CAGR)
IPO
-2.47%
Winner
CURE
+2.34%
10Y(CAGR)
IPO
+10.47%
Winner
CURE
+12.66%
Max(CAGR)
IPO
+8.41%
Winner
CURE
+23.14%
IPO vs CURE - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | IPO | CURE |
|---|---|---|
| 2026 | +13.93% | -10.45% |
| 2025 | +3.34% | +22.87% |
| 2024 | +20.50% | -12.90% |
| 2023 | +55.06% | -8.46% |
| 2022 | -56.71% | -17.91% |
| 2021 | -9.24% | +90.55% |
| 2020 | +104.07% | +4.13% |
| 2019 | +33.94% | +62.36% |
| 2018 | -17.82% | -0.75% |
| 2017 | +36.17% | +62.77% |
| 2016 | +2.36% | -12.42% |
| 2015 | -7.95% | +6.24% |
| 2014 | +7.41% | +83.03% |
| 2013 | +7.55% | +153.15% |
| 2012 | N/A | +45.79% |
| 2011 | N/A | -9.68% |
IPO vs CURE Drawdown Comparison
The maximum drawdown for IPO was -68.76%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The current IPO drawdown is -29.10%. The current CURE drawdown is -28.04%.
| Rank | IPO | CURE |
|---|---|---|
| #1 | -68.76% Feb 12, 2021 - Dec 28, 2022 | -69.19% Jan 22, 2020 - Jan 6, 2021 |
| #2 | -38.47% Feb 19, 2020 - May 20, 2020 | -52.25% Apr 8, 2022 - Aug 7, 2025 |
| #3 | -36.73% Apr 16, 2015 - May 15, 2017 | -48.54% Jul 20, 2015 - Jun 22, 2017 |
| #4 | -31.34% Jun 18, 2018 - May 3, 2019 | -44.44% Jul 1, 2011 - Mar 15, 2012 |
| #5 | -17.59% Jul 26, 2019 - Jan 16, 2020 | -42.27% Oct 1, 2018 - Nov 27, 2019 |
| #6 | -13.19% Mar 5, 2014 - Sep 8, 2014 | -36.35% Jan 26, 2018 - Sep 13, 2018 |
| #7 | -11.58% Oct 13, 2020 - Nov 20, 2020 | -29.28% Dec 30, 2021 - Apr 8, 2022 |
| #8 | -10.96% Sep 11, 2014 - Nov 12, 2014 | -22.89% Aug 17, 2021 - Dec 15, 2021 |
| #9 | -10.76% Sep 1, 2020 - Sep 29, 2020 | -22.59% Sep 24, 2014 - Oct 28, 2014 |
| #10 | -9.40% Dec 22, 2020 - Jan 21, 2021 | -19.78% Mar 4, 2014 - Jun 19, 2014 |
| #11 | -8.14% Aug 5, 2020 - Aug 26, 2020 | -19.31% Oct 17, 2012 - Jan 9, 2013 |
| #12 | -7.39% May 3, 2019 - Jun 18, 2019 | -19.31% Jan 20, 2021 - Apr 15, 2021 |
| #13 | -7.03% Jan 23, 2018 - Mar 6, 2018 | -17.38% Apr 2, 2012 - Jun 29, 2012 |
| #14 | -6.78% Nov 24, 2014 - Feb 11, 2015 | -15.49% May 28, 2013 - Jul 12, 2013 |
| #15 | -6.75% Jul 9, 2020 - Aug 3, 2020 | -14.96% Dec 8, 2014 - Jan 22, 2015 |
Correlation
Correlation between IPO and CURE is 0.69 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.69
-101
Dividend Comparison (2011 - 2026)
IPO vs CURE dividend yield comparison.
| Year | IPO | CURE |
|---|---|---|
| 2026 | 0.06% | 0.28% |
| 2025 | 0.66% | 1.12% |
| 2024 | 0.12% | 1.17% |
| 2023 | 0.00% | 2.02% |
| 2022 | 0.00% | 0.38% |
| 2021 | 0.00% | 0.02% |
| 2020 | 0.10% | 0.17% |
| 2019 | 0.26% | 0.40% |
| 2018 | 0.49% | 0.70% |
| 2017 | 0.43% | 0.18% |
| 2016 | 0.40% | 0.00% |
| 2015 | 0.11% | 0.00% |
| 2014 | 2.45% | 0.00% |
| 2013 | 0.07% | 1.24% |
| 2012 | 0.00% | 0.03% |
| 2011 | 0.00% | 2.10% |
Select Stocks to Compare
Popular: IPO vs SPYCURE vs SPY
More Comparisons
Compare with similar stocks